Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Cash: 2011-2024

Historic Change in Cash for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $17.3 million.

  • Niagen Bioscience's Change in Cash fell 15.44% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 466.97%. This contributed to the annual value of $17.3 million for FY2024, which is 151.82% up from last year.
  • Niagen Bioscience's Change in Cash amounted to $17.3 million in FY2024, which was up 151.82% from $6.9 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Change in Cash registered a high of $17.3 million during FY2024, and its lowest value of -$7.8 million during FY2022.
  • For the 3-year period, Niagen Bioscience's Change in Cash averaged around $5.5 million, with its median value being $6.9 million (2023).
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 644.78% in 2021, then slumped by 167.51% in 2022.
  • Niagen Bioscience's Change in Cash (Yearly) stood at -$2.1 million in 2020, then skyrocketed by 644.78% to $11.5 million in 2021, then crashed by 167.51% to -$7.8 million in 2022, then soared by 188.51% to $6.9 million in 2023, then skyrocketed by 151.82% to $17.3 million in 2024.